Investor Alert

Company Close Updates Archives | Email alerts

Dec. 2, 2020, 5:02 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 8.28% to $1.33 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.20% to 29,883.79 and the NASDAQ Composite Index COMP falling 0.05% to 12,349.37. Corbus Pharmaceuticals Holdings Inc. closed $8.45 short of its 52-week high ($9.78), which the company achieved on August 31st.

The stock underperformed when compared to some of its competitors Wednesday, as Fate Therapeutics Inc. FATE rose 0.51% to $60.53, Vanda Pharmaceuticals Inc. VNDA rose 9.32% to $13.49, and Viking Therapeutics Inc. VKTX fell 0.48% to $6.23. Trading volume (6.8 M) eclipsed its 50-day average volume of 4.7 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.